These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 19642297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Contribution to the evaluation of serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and in individual clinical stages of multiple myeloma].
    Scudla V, Petrová P, Minarík J, Pika T, Budíková M, Bacovský J, Repovský S.
    Vnitr Lek; 2010 Jun; 56(6):591-601. PubMed ID: 20681472
    [Abstract] [Full Text] [Related]

  • 5. Analysis of the serum levels of selected biological parameters in monoclonal gammopathy of undetermined significance and different stages of multiple myeloma.
    Scudla V, Petrova P, Minarik J, Pika T, Bacovsky J.
    Neoplasma; 2011 Jun; 58(6):499-506. PubMed ID: 21895403
    [Abstract] [Full Text] [Related]

  • 6. A contribution to examination of propidium iodide and annexin V plasma cells indices in multiple myeloma.
    Scudla V, Ordeltova M, Bacovsky J, Vytrasova M, Sumna E, Martinek A, Horak P.
    Neoplasma; 2003 Jun; 50(5):363-71. PubMed ID: 14628090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The importance of serum levels of selected biological parameters in the diagnosis, staging and prognosis of multiple myeloma.
    Scudla V, Pika T, Budikova M, Petrova J, Minarik J, Bacovsky J, Langova K, Zivna J, Czech Myeloma Group.
    Neoplasma; 2010 Jun; 57(2):102-10. PubMed ID: 20099972
    [Abstract] [Full Text] [Related]

  • 9. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
    Ščudla V, Petrová P, Pika T, Lochman P, Minařík J, Bačovský J, Srovnalík K.
    Cas Lek Cesk; 2015 Jun; 154(4):181-8. PubMed ID: 26357861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The significance of soluble CD138 in diagnosis of monoclonal gammopathies.
    Maisnar V, Tousková M, Tichý M, Krejsek J, Chrobák L, Voglová J, Malý J.
    Neoplasma; 2006 Jun; 53(1):26-9. PubMed ID: 16416009
    [Abstract] [Full Text] [Related]

  • 14. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O, Heider U, Zavrski I, Possinger K.
    Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
    [Abstract] [Full Text] [Related]

  • 15. Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
    Woitge HW, Pecherstorfer M, Horn E, Keck AV, Diel IJ, Bayer P, Ludwig H, Ziegler R, Seibel MJ.
    Br J Cancer; 2001 Feb 02; 84(3):344-51. PubMed ID: 11161399
    [Abstract] [Full Text] [Related]

  • 16. Soluble syndecan-1 levels in different plasma cell dyscrasias and in different stages of multiple myeloma.
    Jánosi J, Sebestyén A, Mikala G, Németh J, Kiss Z, Vályi-Nagy I.
    Haematologica; 2004 Mar 02; 89(3):370-1. PubMed ID: 15020284
    [Abstract] [Full Text] [Related]

  • 17. [Soluble syndecan-1 levels in different plasma cell dyscrasias].
    Jánosi J, Sebestyén A, Mikala G, Petö M, Jákó J, Domján G, Németh J, Kis Z, Kopper L, Vályi-Nagy I.
    Orv Hetil; 2005 Jan 23; 146(4):165-8. PubMed ID: 15751511
    [Abstract] [Full Text] [Related]

  • 18. [Study of monoclonal gammopathy in Kagawa Prefectural Central Hospital].
    Uchida M, Taida N, Kanao M, Kagamihara H, Kuwajima M.
    Rinsho Byori; 2004 Jul 23; 52(7):574-9. PubMed ID: 15344556
    [Abstract] [Full Text] [Related]

  • 19. [Monitoring markers of bone turnover in multiple myeloma].
    Spicka I, Spacek P, Hulejová H, Procházka B, Cieslar P, Chrz M, Válková V, Klener P.
    Vnitr Lek; 1999 Aug 23; 45(8):463-7. PubMed ID: 11045145
    [Abstract] [Full Text] [Related]

  • 20. Kynurenic acid in blood and bone marrow plasma of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) patients.
    Zdzisińska B, Wejksza K, Walter-Croneck A, Turski WA, Kandefer-Szerszeń M.
    Leuk Res; 2010 Jan 23; 34(1):38-45. PubMed ID: 19596432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.